Changes in full blood count parameters in leptospirosis: a prospective study
© De Silva et al.; licensee BioMed Central Ltd. 2014
Received: 26 February 2014
Accepted: 14 June 2014
Published: 21 June 2014
Leptospirosis presents diagnostic challenges to clinicians, in settings where other acute febrile illness are prevalent. The patterns of serial changes in haematological parameters in leptospirosis has not been evaluated previously.
Clinical and laboratory data were collected prospectively from patients with leptospirosis in two hospitals in Sri Lanka. Leptospirosis was diagnosed based on WHO clinical criteria with confirmation using Microscopic Agglutination Test titre > 400 or 4 fold rise between acute and convalescent samples. Full blood count parameters were analysed up to the 14th day of illness.
Data from 201 patients with leptospirosis were available. Leukocyte counts and absolute neutrophil counts showed a decline over the first 5 days of illness, then rose until the end of the second week. On day 3 of fever, the majority (75%) had normal leukocyte counts, and by day 5, leukocytosis was seen only in 38.1%; leucopenia was an uncommon finding. Lymphopenia was seen in over half on day 5, declining to just under a quarter of patients by day 10. Platelets declined over the first 6 days and then gradually rose. Thrombocytopenia was seen in nearly three-fourths of patients by day 5. Haemoglobin and haematocrit levels declined over the course of illness. Total white cell and neutrophil counts were higher, and haemoglobin and haematorcrit were significantly lower, in patients with severe disease.
Neither leukocytosis nor lymphopenia were prominent features, while thrombocytopenia was seen during the 3rd to 5th day of illness, with dropping haemoglobin levels. Neutrophilia and low haemoglobin levels appear to predict severe disease. These findings may be of use to clinicians in differentiating leptospirosis from other acute infections like dengue, and could help in predicting severe leptospirosis.
Leptospirosis presents diagnostic challenges to the clinicians in the presence of other acute febrile illnesses such as dengue and typhus. Laboratory confirmation is often delayed, and clinicians treat leptospirosis based on clinical suspicion. The patterns of simple laboratory investigations are of potential use to the clinician in differentiating febrile tropical diseases. Changes in full blood counts in leptospirosis have been examined in two studies, however the patterns of serial changes in these parameters have not been examined previously [1, 2]. Higher WBC and neutrophil counts have been demonstrated in patients with severe disease . We conducted this study to determine the patterns of serial changes in full blood counts of patients with leptospirosis, and their relationship to disease severity.
We carried out a prospective hospital-based study. All patients admitted to medical wards of the National Hospital, Colombo and Base Hospital Homagama, Sri Lanka with clinically suspected leptospirosis (based on WHO clinical criteria) were screened during a period of one year beginning May 2012, and those with serologically confirmed leptospirosis (microscopic agglutination test [MAT] >400 or a four-fold rise in titre between acute and convalescent samples)  were enrolled. MAT is the standard test for laboratory confirmation in Sri Lanka. Clinical and laboratory data were recorded until the point of discharge, transfer or death. Patients fulfilling any of the following criteria were defined to have developed severe leptospirosis: renal insufficiency (urine output < 400 ml per day, creatinine > 133 μmol/L, urea > 25.5 mmol/L, dialysis); jaundice (Bilirubin > 51.3 μmol/L), ICU stay, prolonged hospital stay (>10 days), death (note: there is no standard classification of severity for leptospirosis, thus severity was based on the presence of organ dysfunction, indicators of morbidity, and mortality). We analyzed full blood count parameters from admission up to the first 14 days from the onset of febrile illness. Comparison between severity of illness and haematological parameters was performed using two sample t-test.
Platelet counts showed a decline over the first six days of illness and then gradually rose. Thrombocytopenia (<150 × 109/L) was seen in 56.76% of the patients on the third day, and this proportion rose to 73.8% by the fifth day. Thrombocytopaenia was seen in 80.7% at some point during the course of the illness. Haemoglobin levels showed a gradual decline over the course of illness.
The findings described here are of potential use to clinicians in differentiating leptospirosis from viral infections such as dengue, and also bacterial sepsis. Normal or high leukocyte counts, lymphopenia, and lower haemoglobin and haematocrit values could potentially favour a diagnosis of leptospirosis over dengue. The changes in platelet counts are similar to patterns described earlier . Our study supports the finding that thrombocytopaenia is not helpful in differentiating leptospirosis from dengue, as the pattern of reduction in platelet counts shown in this study shows similarities with dengue in the early stages (i.e., day 3 to day 5) of illness. Although neutrophil leukocytosis was not a prominent feature, leukocyte counts are normal throughout the course of illness in the majority; in contrast, nearly all patients develop leukopenia by the 3rd day of illness in dengue . Thus, the absence of leukopenia may differentiate leptospirosis from dengue. Lack of neutrophil leukocytosis may also help differentiate leptospirosis from bacterial sepsis.
In patients in whom a diagnosis of leptospirosis has been made clinically and serologically, the presence of neutrophilia and thrombocytopenia early on in the illness may predict the development of severe disease.
Normal or slightly elevated leukocyte counts are seen in the majority of patients with leptospirosis; lymphopenia is not a characteristic feature, and platelets could be low. A neutrophilic response may predict severe disease. Lower haemoglobin and haematocrit levels on day 3–5 of illness may help differentiate leptospirosis from dengue.
Ethics clearance for the study was obtained from the Ethics Review Committees of the NHSL, and of the Faculty of Medicine, University of Colombo.
Consultants and other Staff of the National Hospital, Colombo and Base Hospital Homagama, Sri Lanka; Staff of the Medical Research Institute, Sri Lanka; and Dr Tharanga Fernando for help with data collection.
Support for this study was provided by National Science Foundation, Sri Lanka Grant No: NSF/2011/HS/19 and National Research Council, Sri Lanka Grant No: 12–077.
- Daher EF, Lima RS, Silva Júnior GB, Silva EC, Karbage NN, Kataoka RS, Carvalho Júnior PC, Magalhães MM, Mota R, Libório AB: Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz J Infect Dis 2010, 14:3–10. 10.1016/S1413-8670(10)70002-7PubMedView ArticleGoogle Scholar
- Craig SB, Graham GC, Burns MA, Dohnt MF, Smythe LD, McKay DB: Lymphopenia is observed regularly in the acute (leptospiraemic) phase but not the immune phase of leptospirosis. Trans R Soc Trop Med Hyg 2009, 103:958–960. 10.1016/j.trstmh.2009.03.019PubMedView ArticleGoogle Scholar
- Craig SB, Graham GC, Burns MA, Dohnt MF, Smythe LD, McKay DB: Haematological and clinical-chemistry markers in patients presenting with leptospirosis: A comparison of the findings from uncomplicated cases with those seen in the severe disease. Ann Trop Med Parasitol 2009, 103:333–341. 10.1179/136485909X435058PubMedView ArticleGoogle Scholar
- Gunaratna RI, Handunnetti SM, Bulathsinghalage MR, Somaratne P, Jayanaga A, de Silva HJ, Rajapakse S: Serum nitrite levels in Sri Lankan patients with leptospirosis. Asian Pac J Trop Med 2012, 5:75–78. 10.1016/S1995-7645(11)60250-2PubMedView ArticleGoogle Scholar
- Premaratna R, Pathmeswaran A, Amarasekara N, Motha M, Perera K, de Silva H: A clinical guide for early detection of dengue fever and timing of investigations to detect patients likely to develop complications. Trans R Soc Trop Med Hyg 2009, 103:127–131. 10.1016/j.trstmh.2008.07.024PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.